This edited volume brings together the expertise of numerous specialists on the topic of particles – their physical, chemical, pharmacological and toxicological characteristics – when they are a component of pharmaceutical products and ...

This authoritative volume explores the fundamental concepts and numerous applications of targeted delivery of drugs to the body.

... S.A., et al., 2003. Pharmacokinetics and pharmacodynamics of abarelix, a ... SynerGene Therapeutics, Inc. 1. Mol. Cancer Ther. 1, 337À346. Xu, L., Tang ... X., et al., 2015. Targeted nanomedicine for prostate cancer therapy: docetaxel and ...

This book clearly demonstrates the progression of nanoparticle therapeutics from basic research to applications.

This book summarizes the latest advances in nanomaterials and techniques in the field of tumor-targeted diagnosis and therapy.

... SynerGene InvivoGen Gliosarcoma Melanoma Neuroblastoma Cancer Pain HSV PhaseI HSV-1 Phase I Brain tumor HSV-1 Phase ... X-linked inherited retinal dystrophy that causes night blindness and a constricted visual field. Mutations in REP1 ...

This book presents detailed, up-to-date information on various aspects of excipient development, testing, and technological considerations for their use.

The focus of this volume is on cancer indication since the majority of published research relates to this application; within that, we focus on solid tumors (solid malignancies).

This book is the third volume on this subject and focuses on the recent advances of nanopharmaceuticals in cancer, dental, dermal and drug delivery applications and presents their safety, toxicity and therapeutic efficacy.

This book is a valuable guide for materials scientists, physicians, chemists and engineers, but is also ideal for clinicians wishing to expand their knowledge.